TriSalus Life Sciences Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | -41.9% | +11.8% | -2.5% | +47.4% | |
| – | -51.0% | +21.2% | -0.9% | +56.0% | |
| – | -68.9% | +25.1% | -27.6% | +139.8% | |
| – | -68.9% | +25.1% | -27.6% | +139.8% | |
| – | +14.7% | +128.3% | +43.1% | +28.9% | |
| – | +13.9% | +73.0% | +59.1% | -24.0% | |
| – | +1.0% | +40.5% | – | – | |
| – | +394.9% | +50.5% | -3.5% | +38.8% | |
| – | +407.7% | -54.6% | -30.4% | +12.4% | |
| – | -99.1% | -5.1% | -38.5% | -22.7% | |
| – | +280.5% | -31.5% | -32.9% | +32.0% | |
| – | – | – | – | +49.6% | |
| – | -139.9% | – | – | – | |
| – | – | – | – | – | |
| – | -5.3% | -10.6% | +0.1% | +43.0% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.